---
title: "Early detection of declining kidney function in a Sri Lankan working-age cohort"
id: "medrxiv-4-detecting-early-loss-of-kidney-function-in-a-sri-lankan-cohort-study-of-working"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-4-detecting-early-loss-of-kidney-function-in-a-sri-lankan-cohort-study-of-working"
content_type: "clinical_feed_article"
specialty: "Nephrology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1?rss=1"
published_at: "2026-08-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Early detection of declining kidney function in a Sri Lankan working-age cohort
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-4-detecting-early-loss-of-kidney-function-in-a-sri-lankan-cohort-study-of-working
- **Specialty:** [Nephrology](https://medichelpline.com/clinical-feed/nephrology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1?rss=1)
- **Published At:** 2026-08-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This longitudinal cohort followed 425 adults aged 20–60 in Puhudivula, Anuradhapura district, Sri Lanka, over six years to detect early loss of kidney function after a 2017 cross-sectional survey suggested community-level risk. - The study excluded individuals with diabetes, hypertension or pre-existing chronic kidney disease to focus on **chronic kidney disease of undetermined cause (CKDu)**-like presentations. - Baseline population data motivating the study: a 2017 survey found low **eGFR** in 11.2% of men and 3.7% of women in North Central Province in the absence of traditional risk factors. - Researchers applied **hidden Markov models** (HMMs) to serial eGFR measurements to estimate latent kidney-health states and to identify transitions between healthy and unhealthy states over time. - Four distinct kidney-health trajectories were identified among participants: always healthy (74%), persistently unhealthy (5%), transition from healthy to unhealthy (10%), and reversion from unhealthy to healthy (11%). - Use of **smokeless tobacco** (including betel quid) was associated with being in an unhealthy category at measured timepoints (odds ratio 2.29; 95% CI 1.17–4.49). - Lagged exposures (prior-period exposures) to smoking (OR 2.26; 95% CI 1.25–4.10), smokeless tobacco (OR 1.98; 95% CI 1.13–3.48) and **weedkiller** (OR 1.72; 95% CI 1.15–2.59) were associated with transition from a healthy to an unhealthy kidney state. - Overall, nearly one quarter of working-age adults in this cohort showed eGFR changes consistent with poor kidney health over the study period. - The authors note ethical approval (EC-25-170) from the University of Colombo Ethics Review Committee and list data availability via contact with Dr Thilanga Ruwanpathirana. Funding sources included the National Science Foundation of Sri Lanka, Ministry of Health Sri Lanka, WHO Country Office Sri Lanka, Medical Research Council, and the Colt Foundation. - As a preprint, findings have not been peer reviewed and should not yet guide clinical practice; supplementary materials and data/code links are provided with the preprint.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=3gE1ZfOnV1FPOBcNdLESVRsyQnhGGbDeQ6zkO1xAkEw-1787283369.7912674-1.2.1.1-lKO_ZADjAENYb8i.sWELUNAvKvZ9kRx2UIOExkSSQR12iD53a_fzJkG1G2bMT6L6) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Detecting early loss of kidney function in a Sri Lankan cohort study of working age adults [ View ORCID Profile](http://orcid.org/0000-0003-2360-1047)Pubudu Chulasiri, [ View ORCID Profile](http://orcid.org/0000-0002-9823-7932)Charlotte E Rutter, Nalika Gunawardena, SC Wickramasinghe, Rimaza Niyas, [ View ORCID Profile](http://orcid.org/0000-0002-9938-7852)Neil Pearce, [ View ORCID Profile](http://orcid.org/0000-0001-9544-164X)Ben Caplin, [ View ORCID Profile](http://orcid.org/0000-0003-3383-8953)Thilanga Ruwanpathirana doi: https://doi.org/10.64898/2026.08.18.26360601 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Pubudu Chulasiri 1 Ministry of Health, Sri Lanka; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pubudu%2BChulasiri%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chulasiri%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APubudu%2BChulasiri%2B) * [ORCID record for Pubudu Chulasiri](http://orcid.org/0000-0003-2360-1047 "Open in new tab") Charlotte E Rutter 2 London School of Hygiene and Tropical Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Charlotte%2BE%2BRutter%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rutter%20CE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ACharlotte%2BE%2BRutter%2B) * [ORCID record for Charlotte E Rutter](http://orcid.org/0000-0002-9823-7932 "Open in new tab") * For correspondence: charlotte.rutter1@lshtm.ac.uk Nalika Gunawardena 3 World Health Organization, Regional Office for South-East Asia; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nalika%2BGunawardena%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Gunawardena%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANalika%2BGunawardena%2B) SC Wickramasinghe 1 Ministry of Health, Sri Lanka; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=SC%2BWickramasinghe%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Wickramasinghe%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASC%2BWickramasinghe%2B) Rimaza Niyas 1 Ministry of Health, Sri Lanka; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rimaza%2BNiyas%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Niyas%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARimaza%2BNiyas%2B) Neil Pearce 2 London School of Hygiene and Tropical Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Neil%2BPearce%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pearce%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANeil%2BPearce%2B) * [ORCID record for Neil Pearce](http://orcid.org/0000-0002-9938-7852 "Open in new tab") Ben Caplin 4 University College London Division of Medicine * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ben%2BCaplin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Caplin%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABen%2BCaplin%2B) * [ORCID record for Ben Caplin](http://orcid.org/0000-0001-9544-164X "Open in new tab") Thilanga Ruwanpathirana 1 Ministry of Health, Sri Lanka; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Thilanga%2BRuwanpathirana%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ruwanpathirana%20T&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AThilanga%2BRuwanpathirana%2B) * [ORCID record for Thilanga Ruwanpathirana](http://orcid.org/0000-0003-3383-8953 "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1281503/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1281503/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1281503/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1281503/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1281503/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1281503/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Chronic kidney disease of undetermined cause (CKDu) is a form of kidney disease not associated with traditional risk factors such as hypertension, diabetes or heavy proteinuria. 11.2% of men and 3.7% of women demonstrated low eGFR (a surrogate for CKDu) in the absence of these risk factors in a 2017 cross-sectional population-representative survey of adults in North Central Province, Sri Lanka. We therefore established a longitudinal cohort to track changes in kidney function over time and to identify risk factors for developing poor kidney health. Methods: This was a 6-year study of adults aged 20-60 years conducted in Puhudivula, Anuradhapura district. Exclusions included evidence of diabetes, hypertension or pre-existing CKD. We fitted hidden Markov models (HMMs) to estimate underlying state of kidney health and examine risk factors associated with departure from a healthy state. Results: We identified four kidney health trajectories in the population (n=425): always healthy (74%); unhealthy throughout (5%); transition from health to unhealthy (10%); and reversion from unhealthy to healthy (11%). Using smokeless tobacco, including betel quid, was associated with being in an unhealthy category (2.29 [1.17, 4.49]). Lagged exposure to smoking (2.26 [1.25, 4.10]), smokeless tobacco (1.98 [1.13, 3.48]) and weedkiller (1.72 [1.15, 2.59]) were associated with the point of transition to an unhealthy state. Conclusions: Almost a quarter of working age adults in this population demonstrated eGFR changes consistent with poor kidney health. Smokeless tobacco use was associated with both pre-existing evidence of poor kidney health and transitioning to the unhealthy category. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethical approval (EC-25-170) was granted by the Ethics Review Committee, Faculty of Medicine, University of Colombo, Sri Lanka. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Information on data availability can be obtained by contacting Dr Thilanga Ruwanpathirana, Ministry of Health, Sri Lanka. ## Funder Information Declared National Science Foundation of Sri Lanka, RPHS/2016/CKDu 07 Ministry of Health, Nutrition and Indigenous Medicine, WHO Country Office Sri Lanka Medical Research Council, MR/P02386X/1 Colt Foundation, https://ror.org/02kcqb193 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.17.26360643v1 "Explainable Clinician-Supervised Artificial Intelligence as an Implementation Framework for Cardiovascular-Kidney-Metabolic Population Health: Synthetic Data Validation of the CHAPERONE-CKM Framework")[Next ](https://www.medrxiv.org/content/10.64898/2026.08.17.26360494v1 "Genome-wide analyses reveal shared and distinct genetic architecture linking amyotrophic lateral sclerosis, sporadic frontotemporal dementia and cognitive traits") Posted August 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/19/2026.08.18.26360601.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.08.18.26360601v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/19/2026.08.18.26360601.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Detecting early loss of kidney function in a Sri Lankan cohort study of working age adults Pubudu Chulasiri, Charlotte E Rutter, Nalika Gunawardena, SC Wickramasinghe, Rimaza Niyas, Neil Pearce, Ben Caplin, Thilanga Ruwanpathirana medRxiv 2026.08.18.26360601; doi: https://doi.org/10.64898/2026.08.18.26360601 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.18.26360601v1%26text%3DDetecting%2520early%2520loss%2520of%2520kidney%2520function%2520in%2520a%2520Sri%2520Lankan%2520cohort%2520study%2520of%2520working%2520age%2520adults "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.18.26360601v1%26t%3DDetecting%2520early%2520loss%2520of%2520kidney%2520function%2520in%2520a%2520Sri%2520Lankan%2520cohort%2520study%2520of%2520working%2520age%2520adults "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.18.26360601v1%26title%3DDetecting%2520early%2520loss%2520of%2520kidney%2520function%2520in%2520a%2520Sri%2520Lankan%2520cohort%2520study%2520of%2520working%2520age%2520adults%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.18.26360601v1%26title%3DDetecting%2520early%2520loss%2520of%2520kidney%2520function%2520in%2520a%2520Sri%2520Lankan%2520cohort%2520study%2520of%2520working%2520age%2520adults "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.18.26360601) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.18.26360601v1&count=horizontal&via=&text=Detecting%20early%20loss%20of%20kidney%20function%20in%20a%20Sri%20Lankan%20cohort%20study%20of%20working%20age%20adults&counturl=www.medrxiv.org/content/10.64898/2026.08.18.26360601v1 "Tweet This") ## Subject Area * [Epidemiology ](https://www.medrxiv.org/collection/epidemiology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (605) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (891) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (324) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4735) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (403) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (637) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1606) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15755) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1192) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6939) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (723) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1048) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4929) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1417) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1726) * [Hematology](https://www.medrxiv.org/collection/hematology) (572) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1320) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16209) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1154) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (657) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (714) * [Neurology](https://www.medrxiv.org/collection/neurology) (7117) * [Nursing](https://www.medrxiv.org/collection/nursing) (359) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1066) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1216) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (990) * [Oncology](https://www.medrxiv.org/collection/oncology) (3557) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1029) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (386) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (442) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (463) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (138) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1764) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (729) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (754) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinica
## Related Clinical Research

- [CHICKADEE study protocol: kidney outcomes and hypertension after pediatric congenital heart diseas](https://medichelpline.com/clinical-feed/plos-one-9-the-congenital-heart-disease-in-children-kidney-associated-conditions-with.md)
- [Long-term Renal Outcomes After Neonatal and Pediatric Renal Vein Thrombosis](https://medichelpline.com/clinical-feed/medrxiv-15-renal-outcomes-in-survivors-of-neonatal-and-pediatric-renal-vein-thrombosis.md)
- [Atherosclerosis in Chronic Kidney Disease: Early Prevention Matters](https://medichelpline.com/clinical-feed/kidney-international-21-atherosclerosis-in-chronic-kidney-disease-early-prevention-is-better-than-late-treatment.md)
- [Use Of Kidney-Preserving Medications In Breastfeeding](https://medichelpline.com/clinical-feed/kidney-international-63-use-of-kidney-preserving-medications-in-breastfeeding.md)
- [Nintedanib-Linked Glomerular Endothelial Injury and Secondary Collapsing FSGS: SGLT2 Inhibitor as](https://medichelpline.com/clinical-feed/pubmed-42674550.md) (DOI: 10.1111/nep.70274)

## Navigation
- [← Back to Nephrology Feed](https://medichelpline.com/clinical-feed/nephrology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.